[肝细胞癌经动脉化疗栓塞术（TACE）后的并发症 - 肝细胞癌经动脉化疗栓塞术（TACE）后的并发症] - Suppr | 超能文献

[Complications after TACE in HCC - complications after transarterial chemoembolization (TACE) in hepatocellular carcinoma].

作者信息

Schneeweiß S, Horger M, Ketelsen D, Ioanoviciu S D

出版信息

Rofo. 2015 Feb;187(2):79-82. doi: 10.1055/s-0034-1369532. Epub 2015 Jan 28.

DOI:10.1055/s-0034-1369532

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Complications after TACE in HCC - complications after transarterial chemoembolization (TACE) in hepatocellular carcinoma].

Rofo. 2015 Feb;187(2):79-82. doi: 10.1055/s-0034-1369532. Epub 2015 Jan 28.

2

Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.

Indian J Cancer. 2015 Feb;51 Suppl 2:e3-8. doi: 10.4103/0019-509X.151984.

3

Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.

Acta Radiol. 2012 Jun 1;53(5):545-50. doi: 10.1258/ar.2012.110476. Epub 2012 Apr 30.

4

Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.

J Clin Gastroenterol. 2010 Sep;44(8):e171-7. doi: 10.1097/MCG.0b013e3181c88235.

5

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.

J Hepatol. 2012 Jun;56(6):1336-42. doi: 10.1016/j.jhep.2012.01.006. Epub 2012 Feb 4.

6

Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma.

J Gastroenterol Hepatol. 2012 Jun;27(6):1051-6. doi: 10.1111/j.1440-1746.2011.06963.x.

7

Assessment and monitoring of liver function by ¹³C-aminopyrine breath test after selective transarterial chemoembolisation of hepatocellular carcinoma.

Z Gastroenterol. 2015 Jan;53(1):21-7. doi: 10.1055/s-0034-1385230. Epub 2015 Jan 16.

8

Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.

Eur J Radiol. 2012 Mar;81(3):466-71. doi: 10.1016/j.ejrad.2010.12.058. Epub 2011 Mar 3.

9

Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.

J Gastroenterol Hepatol. 2009 May;24(5):806-14. doi: 10.1111/j.1440-1746.2008.05728.x. Epub 2009 Jan 13.

10

Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.

Liver Int. 2014 Apr;34(4):612-20. doi: 10.1111/liv.12307. Epub 2013 Sep 13.

引用本文的文献

1

Efficacy and safety of transcatheter arterial chemoembolization combined with sorafenib and sintilimab in the treatment of unresectable hepatocellular carcinoma.

Am J Transl Res. 2024 Dec 15;16(12):7849-7858. doi: 10.62347/KNIV1276. eCollection 2024.

2

Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.

Korean J Radiol. 2018 Mar-Apr;19(2):237-246. doi: 10.3348/kjr.2018.19.2.237. Epub 2018 Feb 22.